{'52WeekChange': 0.068965435,
 'SandP52WeekChange': None,
 'address1': '1455 Adams Drive',
 'address2': 'Suite 2050',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.46,
 'askSize': 1300,
 'averageDailyVolume10Day': 167925,
 'averageVolume': 274723,
 'averageVolume10days': 167925,
 'beta': 2.703641,
 'beta3Year': None,
 'bid': 1.44,
 'bidSize': 1000,
 'bookValue': 0.131,
 'category': None,
 'circulatingSupply': None,
 'city': 'Menlo Park',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.5899,
 'dayLow': 1.39,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -4.372,
 'enterpriseToRevenue': None,
 'enterpriseValue': 56308948,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.9637144,
 'fiftyTwoWeekHigh': 4.25,
 'fiftyTwoWeekLow': 0.87,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 29143716,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 12,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.32467997,
 'heldPercentInstitutions': 0.04774,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/cohbar.com',
 'longBusinessSummary': 'CohBar, Inc., a clinical stage biotechnology company, '
                        'engages in the research and development of '
                        'mitochondria based therapeutics (MBTs) for the '
                        'treatment of diseases associated with aging and '
                        'metabolic dysfunction. The company develops MBTs to '
                        'treat non-alcoholic steatohepatitis (NASH), obesity, '
                        'fatty liver disease, type 2 diabetes mellitus, '
                        'cancer, atherosclerosis, cardiovascular disease, and '
                        "neurodegenerative disease, such as Alzheimer's "
                        'disease. Its lead MBT candidate is CB4211, a novel '
                        'optimized analog of the MOTS-c mitochondrial-derived '
                        'peptide for the treatment of NASH and obesity. The '
                        'company was founded in 2007 and is headquartered in '
                        'Menlo Park, California.',
 'longName': 'CohBar, Inc.',
 'market': 'us_market',
 'marketCap': 63030244,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_134282175',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -14341751,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.55,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '650-446-7888',
 'previousClose': 1.55,
 'priceHint': 4,
 'priceToBook': 11.145039,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.5899,
 'regularMarketDayLow': 1.39,
 'regularMarketOpen': 1.55,
 'regularMarketPreviousClose': 1.55,
 'regularMarketPrice': 1.55,
 'regularMarketVolume': 175586,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 43171400,
 'sharesPercentSharesOut': 0.0070999996,
 'sharesShort': 306324,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 50445,
 'shortName': 'CohBar, Inc.',
 'shortPercentOfFloat': 0.0105,
 'shortRatio': 0.72,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'CWBR',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.334,
 'twoHundredDayAverage': 2.0080576,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'ab587fbc-e016-338d-8cc8-26b30e125ce5',
 'volume': 175586,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.cohbar.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94025'}